Related references
Note: Only part of the references are listed.Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Thomas Ruzicka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
Heike M. Hermanns
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice
K. Kasutani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases
Anja Rabenhorst et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1
Ferda Cevikbas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Dendritic Cells Activated by IFN-γ/STAT1 Express IL-31 Receptor and Release Proinflammatory Mediators upon IL-31 Treatment
Jutta Horejs-Hoeck et al.
JOURNAL OF IMMUNOLOGY (2012)
The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms
Ralf Baumann et al.
Clinical and Translational Allergy (2012)
Early immune events in the induction of allergic contact dermatitis
Daniel H. Kaplan et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells
C. Cornelissen et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins
S. Kasraie et al.
ALLERGY (2010)
IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M
Janine Bilsborough et al.
JOURNAL OF IMMUNOLOGY (2010)
Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells
Francois Niyonsaba et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-33 is a crucial amplifier of innate rather than acquired immunity
Keisuke Oboki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders
Takefumi Ishii et al.
BLOOD (2009)
Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis
Oystein Grimstad et al.
EXPERIMENTAL DERMATOLOGY (2009)
Correlation of IL-31 serum levels with severity of atopic dermatitis
Ulrike Raap et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma
Z. Lei et al.
ALLERGY (2008)
Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response
Wai K. Ip et al.
IMMUNOLOGY (2007)
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Julia Dambacher et al.
GUT (2007)
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
Jacqueline G. Perrigoue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Mark M. Neis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Mast cell-associated TNF promotes dendritic cell migration
Hajime Suto et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-31: A new link between T cells and pruritus in atopic skin inflammation
E Sonkoly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis
A Takaoka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
SR Dillon et al.
NATURE IMMUNOLOGY (2004)
Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity
H Yokozeki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
